Back to Search Start Over

Familial hypokalemic periodic paralysis: a case induced by concurrent hyperthyroidism.

Authors :
Hannouneh ZA
Cervantes CE
Sperati CJ
Hanouneh M
Source :
BMC nephrology [BMC Nephrol] 2024 Sep 27; Vol. 25 (1), pp. 315. Date of Electronic Publication: 2024 Sep 27.
Publication Year :
2024

Abstract

Background: Familial hypokalemic periodic paralysis (HypoPP) is an uncommon genetic disorder characterized by recurrent episodes of muscle weakness and hypokalemia, typically starting in early adulthood. The existence of hyperthyroidism in the presence of HypoPP is more strongly associated with a diagnosis of thyrotoxic periodic paralysis (TPP), with most cases occurring in Asian males with pathogenic KCNJ2 or KCNJ18 variants and without a family history of the condition. This case is novel due to the combination of familial HypoPP and hyperthyroidism induced by Graves' disease, a rare occurrence especially in non-Asian populations.<br />Case Presentation: A 40-year-old African American man presented with profound muscle weakness after consuming a high-salt meal. He had a significant family history of hyperthyroidism and hypokalemia. On examination, he showed profound weakness in all extremities. Laboratory tests confirmed hypokalemia and hyperthyroidism, and genetic testing identified a pathogenic variant in the CACNA1S gene (c.1583 G > A, p. R528H), with normal SCN4A, KCNJ2 and KCNJ18 sequencing. He was diagnosed with familial HypoPP and hyperthyroidism due to Graves' disease. He was started on PO methimazole 10 mg three times a day and PO acetazolamide 250 mg twice a day. He was advised to follow a low carbohydrate and low salt diet.<br />Conclusions: This case highlights the importance of considering a genetic basis for HypoPP in patients with a family history of the condition, even when hyperthyroidism is present. The combination of familial HypoPP and Graves' disease is rare and emphasizes the need for careful genetic and clinical evaluation in similar cases. Management should focus on correcting hypokalemia, treating hyperthyroidism, and lifestyle modifications to prevent recurrence.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1471-2369
Volume :
25
Issue :
1
Database :
MEDLINE
Journal :
BMC nephrology
Publication Type :
Academic Journal
Accession number :
39333966
Full Text :
https://doi.org/10.1186/s12882-024-03749-x